Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wesnes

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
BMC Neurology|June 9, 2011
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive batteryChris Edgar, Peter J Jongen, Evert Sanders, et al.
Brain Injury|September 3, 2014
Atomoxetine for attention deficits following traumatic brain injury: results from a randomized controlled trialDavid L Ripley, Clare E Morey, Don Gerber, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 22, 2012
Relationship between cognition, magnetic resonance white matter hyperintensities, and cardiovascular autonomic changes in late-life depressionAkshya Vasudev, Brian K Saxby, John T OʼBrien, et al.
Journal of Hepatology|June 10, 2008
Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy studyDaniel M Forton, Gavin Hamilton, Joanna M Allsop, et al.
Innovations in Clinical Neuroscience|April 8, 2017
Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial NeedsHolly Posner, Rosie Curiel, Chris Edgar, et al.
Innovations in Clinical Neuroscience|April 8, 2017
Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease SpectrumPhilip D Harvey, Stephanie Cosentino, Rosie Curiel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2002
A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexoneBarbara J Mason, Anita M Goodman, Russell M Dixon, et al.
Psychopharmacology|September 9, 2011
The scopolamine model as a pharmacodynamic marker in early drug developmentRobert A Lenz, Jeffrey D Baker, Charles Locke, et al.
Stroke|May 1, 2004
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patientsEmma J Burton, Rose Anne Kenny, John O'Brien, et al.
Dementia and Geriatric Cognitive Disorders|December 29, 2006
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodiesElise Rowan, Ian G McKeith, Brian K Saxby, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
BMC Neurology|June 9, 2011
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive batteryChris Edgar, Peter J Jongen, Evert Sanders, et al.
Brain Injury|September 3, 2014
Atomoxetine for attention deficits following traumatic brain injury: results from a randomized controlled trialDavid L Ripley, Clare E Morey, Don Gerber, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 22, 2012
Relationship between cognition, magnetic resonance white matter hyperintensities, and cardiovascular autonomic changes in late-life depressionAkshya Vasudev, Brian K Saxby, John T OʼBrien, et al.
Journal of Hepatology|June 10, 2008
Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy studyDaniel M Forton, Gavin Hamilton, Joanna M Allsop, et al.
Innovations in Clinical Neuroscience|April 8, 2017
Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial NeedsHolly Posner, Rosie Curiel, Chris Edgar, et al.
Innovations in Clinical Neuroscience|April 8, 2017
Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease SpectrumPhilip D Harvey, Stephanie Cosentino, Rosie Curiel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2002
A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexoneBarbara J Mason, Anita M Goodman, Russell M Dixon, et al.
Psychopharmacology|September 9, 2011
The scopolamine model as a pharmacodynamic marker in early drug developmentRobert A Lenz, Jeffrey D Baker, Charles Locke, et al.
Stroke|May 1, 2004
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patientsEmma J Burton, Rose Anne Kenny, John O'Brien, et al.
Dementia and Geriatric Cognitive Disorders|December 29, 2006
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodiesElise Rowan, Ian G McKeith, Brian K Saxby, et al.
Pageof 7